Biosimilars Update: FDA Panel Voted to Approve Biosimilars for Etanercept & Adalimumab at July Meeting

Michele B. Kaufman, PharmD, CGP, RPh, is a freelance medical writer based in New York City and a pharmacist at New York Presbyterian Lower Manhattan Hospital.

References

1. U.S. Food and Drug Administration. Advisory Committee Calendar: July 13, 2016: Arthritis advisory committee meeting announcement. 2016 Jun 13.
2. Amgen Inc. News release: Amgen announces FDA advisory committee meeting to review ABP 501, a biosimilar candidate to adalimumab. 2016 Jun 13.
3. U.S. Food and Drug Administration. Advisory Committee Calendar: July 12, 2016: Arthritis advisory committee meeting announcement. 2016 Jun 15.